A systematic review and meta-analysis of trials using statins in pulmonary arterial hypertension.
Statins improve pulmonary vascular remodeling and right ventricular hypertrophy in animal models of pulmonary arterial hypertension (PAH). However, clinical trials assessing the efficacy of statins in patients with PAH have reported mixed results. In this systematic review and meta-analysis, we assess the efficacy of statins in patients with PAH. We included randomized controlled clinical trials (RCTs) that evaluated the efficacy of statins in patients with PAH. Primary outcomes were mortality and change in 6-minute walk distance (6MWD). Data are presented as odds ratio (OR) and weighted mean difference (WMD), with 95% confidence intervals (CIs), for binary and continuous variables, respectively. We included 4 RCTs of high quality. The mean age of participants was 42 ± 13 years, and 70% were women. The statins used were simvastatin at 40-80 mg in two trials, atorvastatin 10 mg in one trial, and rosuvastatin 10 mg in the other. In the pooled-data analysis, there was no statistically significant improvement in mortality (OR: 0.75 [95% CI: 0.32-1.74]), 6MWD (WMD: -9.27 [95% CI: -27.73 to 9.20]), or cardiac index (WMD: 0.11 [95% CI: -0.04 to 0.27]) with statin therapy when compared to placebo. There was no difference in adverse events leading to withdrawal of therapy between statin and placebo groups. These data suggest that statins are not beneficial in the treatment of PAH. There is a need for large, well-conducted clinical trials assessing the effects of statins in patients with PAH. Future trials should include homogeneous patient populations and should be long-term, event-driven trials with combined morbidity and mortality end points.
Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Vidhu
V
Anand
Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Sushil
S
Garg
Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Sue
S
Duval
Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Thenappan
T
Thenappan
hemodynamics; pulmonary embolism; right ventricle; vascular remodeling
N Engl J Med. 2015 Dec 24;373(26):2522-33
26699168
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D4-12
24355640
Open Med. 2009;3(3):e123-30
21603045
Pharmacol Ther. 2003 Jul;99(1):95-112
12804701
Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H938-45
12750068
Ann Med. 2000 Apr;32(3):164-76
10821323
Circulation. 2010 Jul 13;122(2):164-72
20585012
Braz J Med Biol Res. 2008 Aug;41(8):657-63
18797697
Circulation. 2014 Dec 9;130(24):2189-208
25602947
N Engl J Med. 2013 Aug 29;369(9):809-18
23984728
Circulation. 2003 Sep 30;108(13):1640-5
12963647
Circulation. 2013 Mar 12;127(10):1128-38
23403476
Eur Respir J. 2012 Jul;40(1):67-74
22362846
Int J Clin Pharmacol Ther. 2000 May;38(5):270-2
10839471
Circulation. 2011 Jun 28;123(25):2985-93
21593252
Iran Red Crescent Med J. 2013 Aug;15(8):649-54
24578830
N Engl J Med. 2004 Oct 14;351(16):1655-65
15483284
Am J Physiol Heart Circ Physiol. 2008 Feb;294(2):H801-9
18055512
Clin Sci (Lond). 2009 Mar;116(6):497-505
18831711
J Heart Lung Transplant. 2015 Nov;34(11):1366-75
26210752
N Engl J Med. 2015 Aug 27;373(9):834-44
26308684
Eur Respir J. 2010 May;35(5):1079-87
20032020
Am J Physiol Lung Cell Mol Physiol. 2007 Oct;293(4):L933-40
17675370
Circulation. 2010 Jul 13;122(2):156-63
20585011
Am J Respir Crit Care Med. 2010 May 15;181(10):1106-13
20460548
Am J Respir Crit Care Med. 2002 Nov 15;166(10):1403-8
12406854
Chest. 2005 Apr;127(4):1446-52
15821229